Answers are grounded in this paper and cite their sources.
Vascular Ehlers-Danlos syndrome (vEDS), caused by damaging variants in the type III procollagen gene, COL3A1, has a median survival of 51 years. 1 Dominant-negative (DN) variants, missense glycine substitutions within the triple helical domain and splicing variants altering in-phase exons, are considered more severe than haploinsufficiency (HI) variants, premature termination codons causing mRNA instability (i.e., frameshift, non-sense, large deletions).1,2 Penetrance, estimated from patients with vEDS, is high; ≥ 80% of genotypepositive individuals have ≥ one major complication.3 Increasingly, deleterious COL3A1 genotypes are identified through genomic screening programs, yet clinical risks in such unselected populations are not yet defined.We therefore used a genotype-first approach to minimize ascertainment bias, investigating vEDS-associated phenotypes among COL3A1 + biobank participants.Mount Sinai's BioMe biobank (median age 64, IQR 49-75 years; 58.4% Female; 22% African American (AA), 27% European American, 34% Hispanic/Latinx, 4% Asian), links 32,344 patients' exome sequences to their longitudinal electronic health records (EHR), and the United Kingdom Biobank (UKBB), a prospective cohort study, contains phenotypic data and exome sequences for 200,643 participants (median age 57 ± 8 years; 54% Female; 94% white, 2% Asian, 2% Black).Exomes were queried for putatively damaging COL3A1 variants: rare (minor allele frequency < 0.1% in gnomAD) and (1) triple helical domain (exons 6-47) 3 missense glycine substitutions; (2) stop-loss/start-gain; (3) frameshift insertion/deletion; or (4) canonical splice site variant within two base pairs of the exon.
No takes yet. Share an insight, caveat, or question.
Lui et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: